1. Home
  2. ACET vs SOTK Comparison

ACET vs SOTK Comparison

Compare ACET & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.38

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$5.32

Market Cap

73.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
SOTK
Founded
1947
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
77.3M
73.7M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
ACET
SOTK
Price
$7.38
$5.32
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$48.33
N/A
AVG Volume (30 Days)
99.0K
40.6K
Earning Date
05-06-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.50
EPS
N/A
0.11
Revenue
N/A
$20,909,315.00
Revenue This Year
N/A
$4.02
Revenue Next Year
N/A
$10.95
P/E Ratio
N/A
$47.55
Revenue Growth
N/A
1.97
52 Week Low
$0.46
$3.23
52 Week High
$9.47
$5.74

Technical Indicators

Market Signals
Indicator
ACET
SOTK
Relative Strength Index (RSI) 42.41 56.04
Support Level $6.28 $3.79
Resistance Level $8.68 $5.70
Average True Range (ATR) 0.54 0.37
MACD -0.15 -0.01
Stochastic Oscillator 11.01 63.95

Price Performance

Historical Comparison
ACET
SOTK

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: